The year 2020 was a year when the global pharmaceutical industry was profoundly affected by the epidemic. It was also a year when China’s API industry withstood the test of fluctuations in the international market. According to the preliminary statistics of China Chamber of Commerce for Medical Insurance, in 2020, China’s API exports reached us $35.7 billion, another record high, with a year-on-year growth of about 6%.
Storage conditions play a significant role in preserving light-sensitive APIs. It is advisable to maintain these compounds in controlled environments, away from direct sunlight and heat sources. Pharmacies, hospitals, and individuals must be educated on the proper storage practices for such medications to ensure that their potency is maintained throughout their intended use.
As the pharmaceutical landscape evolves, the development of APIs is becoming increasingly complex. With the rise of personalized medicine, there's a growing need for APIs tailored to individual patient profiles. Biopharmaceuticals, for instance, often require the use of biologics as APIs, leading to advancements in bioprocessing techniques and regulatory frameworks.
Sulfamic acid, with the chemical formula H₃NSO₃, is an interesting and multifunctional compound widely used in various industrial applications. This colorless crystalline solid is known for its high solubility in water and its relatively low toxicity compared to other acidic compounds, making it a useful choice in various settings.